Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0000898432-20-000118)

Filing Details

Accession Number:
0000898432-20-000118
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-20 16:04:57
Reporting Period:
2020-02-18
Accepted Time:
2020-02-20 16:04:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1325618 Iradimed Corp IRMD () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1253352 K Monty Allen C/O Iradimed Corporation
1025 Willa Springs Dr.
Winter Springs FL 32708		 No No No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-02-18 2,136 $7.10 23,419 No 4 M Direct
Common Stock Disposition 2020-02-18 2,136 $26.12 21,283 No 4 S Direct
Common Stock Acquisiton 2020-02-19 2,864 $7.10 24,147 No 4 M Direct
Common Stock Disposition 2020-02-19 2,864 $26.00 21,283 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2020-02-18 2,136 $0.00 2,136 $7.10
Common Stock Stock Option (Right to Buy) Acquisiton 2020-02-19 2,864 $0.00 2,864 $7.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,864 No 4 M Direct
5,000 No 4 M Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $26.00 to $26.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. This transaction was executed in multiple trades at prices ranging from $26.00 to $26.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This option, representing a right to purchase a total of 10,000 shares, was granted on 9/29/2014 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.